期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
预后营养指数评估弥漫性大B细胞淋巴瘤患者预后的临床价值 被引量:7
1
作者 宋腾 张亚瑞 +4 位作者 赵可 李书苹 常智 柳凤亭 王华庆 《中国肿瘤临床》 CAS CSCD 北大核心 2019年第17期903-908,共6页
目的:探讨预后营养指数(prognostic nutritional index,PNI)与弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)患者临床特征及预后之间的关系。方法:回顾性收集2010年6月至2016年6月于天津市人民医院收治的82例初治DLBCL患... 目的:探讨预后营养指数(prognostic nutritional index,PNI)与弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)患者临床特征及预后之间的关系。方法:回顾性收集2010年6月至2016年6月于天津市人民医院收治的82例初治DLBCL患者的临床资料,计算PNI值,采用受试者工作特征曲线(ROC)计算Youden指数,获取PNI最佳分界值,分析不同PNI水平与患者临床特征、治疗疗效及预后的关系。结果:全组患者PNI均值为43.93±5.86,当PNI值为44.15时,Youden指数最大,敏感度为74.6%,特异度为67.2%。低PNI组(<44.15)和高PNI组(≥44.15)患者分别占38例(46.3%)和44例(53.7%),PNI水平与患者的ECOG PS评分、Ann Arbor分期、IPI评分、LDH水平等均有相关性(均P<0.05)。低PNI组患者化疗总有效率低于高PNI组(65.8%vs.86.4%),且差异具有统计学意义(χ^2=4.848,P=0.028)。全组患者3年生存率为69.1%,低PNI组1、2、3年生存率分别为86.8%、67.8%和56.9%,均低于高PNI组96.7%、89.5%和80.2%,差异具有统计学意义(χ^2=9.421,P=0.002)。单因素分析显示患者PNI值<44.15、ECOG PS评分≥2分、IPI评分>2分、分期Ⅲ~Ⅳ期、外周血淋巴细胞计数<1.0×10^9/L对预后有影响(均P<0.05),多因素分析显示PNI值<44.15和Ⅲ/Ⅳ期为影响该组患者的独立预后不良因素(P=0.006,0.011)。结论:PNI值可作为DLBCL患者简便可行的临床预后指标。 展开更多
关键词 弥漫大B细胞淋巴瘤 预后营养指数 预后 化疗
暂未订购
The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility
2
作者 Xiaoting Hou Yu Chen +8 位作者 Bo Zhou fengting liu Lingyun Dai Chunbo Chen Noah D.Carrillo Vincent L.Cryns Richard A.Anderson Jichao Sun Mo Chen 《Protein & Cell》 2025年第10期840-857,共18页
Dysregulation of p53 and phosphoinositide(PIP_(n)) signaling are both key drivers of oncogenesis and metastasis.Our recent findings reveal a previously unrecognized interaction between these pathways,converging in the... Dysregulation of p53 and phosphoinositide(PIP_(n)) signaling are both key drivers of oncogenesis and metastasis.Our recent findings reveal a previously unrecognized interaction between these pathways,converging in the nucleus to form a PIP_(n)-p53 signalosome that modulates nuclear AKT activation and downstream signaling,thereby influencing cancer cell survival and motility.This review examines recent insights into nuclear PIP_(n)signaling in the context of established roles for p53 in cell dynamics and migration while also deliberating current research on how nuclear PIP_(n)s interact with p53 to form signalosomes that affect cell motility.We emphasize the critical role of PIP_(n)in stabilizing p53 and activating de novo nuclear AKT signaling,which subsequently modulates key motility-related pathways.Understanding the unique operation and function of the PIP_(n)-p53 signalosome in nuclear phosphatidylinositol 3-kinase(PI3K)-AKT activation offers novel therapeutic strategies for controlling cancer metastasis by targeting pertinent interactions and events. 展开更多
关键词 PHOSPHOINOSITIDE P53 SIGNALOSOME NUCLEUS cell motility
暂未订购
Self-synthesized second mitochondria-derived activator of caspase(SMAC)mimetic TP-WY-1345 enhances the radiosensitivity of NSCLC cells H1299 by targeting anti-apoptotic protein cIAP1
3
作者 Hao Sun fengting liu +8 位作者 Hezheng Zhai Jiang Wu Shasha Nie Hui Cai Kaixue Wen Li Feng Qiang liu Kaihua Ji Yan Wang 《Radiation Medicine and Protection》 CSCD 2023年第1期26-32,共7页
Objective:To explore the toxicity and cellular uptake of the self-synthesized second mitochondria-derived activator of caspase(SMAC)mimetic TP-WY-1345 polypeptide and its radiosensitizing effect on non-small cell lung... Objective:To explore the toxicity and cellular uptake of the self-synthesized second mitochondria-derived activator of caspase(SMAC)mimetic TP-WY-1345 polypeptide and its radiosensitizing effect on non-small cell lung cancer(NSCLC).Methods:A fluorescence microscope was used to observe the uptake efficiency of TP-WY-1345 by human NSCLC cells H1299.Toxicity of the TP-WY-1345 peptide in normal cells was examined in human embryonic lung fibroblasts MRC5.CCK-8 and clone formation experiments were performed to detect the radiosensitizing effect of TP-WY-1345 in the H1299 cells.The AutoDock Vina simulation software was employed to predict the binding efficiency of TP-WY-1345 to the inhibitor of apoptosis proteins(IAPs).Moreover,Western blot and qPCR experiments were carried out to determine the protein and gene expressions,and the flow cytometry(FCM)technique was used to detect the apoptosis level under different conditions.Results:TP-WY-1345 can be self-synthesized,and significant green fluorescence was observed in H12992 h and 6 h after incubation with TP-WY-1345.The cell counting and CCK-8 results showed that 10μmol/L and 20μmol/L TP-WY-1345 did not produce a significant toxic effect on the MRC5 cells(P>0.05).Compared with the single ionizing radiation group,the cell viability and clone formation of H1299 cells were significantly inhibited after treatment with TP-WY-1345 at a concentration of 50μmol/L(P<0.05).The sensitivity enhancement ratio(SER)was calculated to be 1.14.Moreover,the binding efficiency of TP-WY-1345 to cIAP1 protein was predicted to be7.3,and this strong binding force was demonstrated by Western blot.TP-WY-1345 inhibited the protein and mRNA expressions of cIAP1 and further increased the apoptosis level of the H1299 cells at 24 h(P<0.01)and 48 h after radiation(P<0.05).Conclusion:SMAC mimetic TP-WY-1345 can enter the H1299 cells and produce a radiosensitizing effect by increasing the level of radiation-induced apoptosis of the cells.There,TP-WY-1345 is expected to become a new generation of radiosensitizing drugs. 展开更多
关键词 TP-WY-1345 Radiosensitizing SMAC mimetic IAP Non-small cell lung cancer
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部